These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1863306)

  • 1. Container residue of activated charcoal products.
    Harchelroad F
    Am J Emerg Med; 1991 Sep; 9(5):520. PubMed ID: 1863306
    [No Abstract]   [Full Text] [Related]  

  • 2. Container residue after the administration of aqueous activated charcoal products.
    Krenzelok EP; Lush RM
    Am J Emerg Med; 1991 Mar; 9(2):144-6. PubMed ID: 1994942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Container residue after activated charcoal administration in the emergency department.
    Harchelroad F
    Vet Hum Toxicol; 1992 Feb; 34(1):13-4. PubMed ID: 1621355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of sorbitol in multiple-dose activated charcoal regimens in emergency departments.
    Wax PM; Wang RY; Hoffman RS; Mercurio M; Howland MA; Goldfrank LR
    Ann Emerg Med; 1993 Dec; 22(12):1807-12. PubMed ID: 8239100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal transit times of cathartics used with activated charcoal.
    Krenzelok EP
    Clin Pharm; 1985; 4(4):446-8. PubMed ID: 4042559
    [No Abstract]   [Full Text] [Related]  

  • 6. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose.
    McNamara RM; Aaron CK; Gemborys M; Davidheiser S
    Ann Emerg Med; 1988 Mar; 17(3):243-6. PubMed ID: 3345017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and optimization of the activated charcoal suspension composition based on a mixture design approach.
    Ronowicz J; Kupcewicz B; Pałkowski Ł; Krysiński J
    Acta Pharm; 2015 Mar; 65(1):83-90. PubMed ID: 25781707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive doses of the activated charcoal-sorbitol combination: a word of caution.
    Sullivan JB; Krenzelok EP
    Am J Emerg Med; 1988 Mar; 6(2):201-3. PubMed ID: 3355629
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrointestinal transit times of cathartics combined with charcoal.
    Krenzelok EP; Keller R; Stewart RD
    Ann Emerg Med; 1985 Dec; 14(12):1152-5. PubMed ID: 4061985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral administration of activated charcoal-sorbitol suspension as first aid in prevention of poison resorption?].
    Eyer P; Sprenger M
    Klin Wochenschr; 1991 Nov; 69(19):887-94. PubMed ID: 1812318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption.
    Keller RE; Schwab RA; Krenzelok EP
    Ann Emerg Med; 1990 Jun; 19(6):654-6. PubMed ID: 2188536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory study; the therapeutic effects of premixed activated charcoal-sorbitol administration in patients poisoned with organophosphate pesticide.
    Moon J; Chun B; Song K
    Clin Toxicol (Phila); 2015 Feb; 53(2):119-26. PubMed ID: 25608917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of activated charcoal for per os administration to addicted subjects.
    Flament MP; M'bisi R; Leterme P; Gayot AT
    Drug Dev Ind Pharm; 2000 Jul; 26(7):731-6. PubMed ID: 10872091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose.
    Mayersohn M; Perrier D; Picchioni AL
    Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose activated charcoal: an ever-expanding role.
    Krenzelok EP; Lopez GP
    Ann Emerg Med; 1988 Oct; 17(10):1134-5. PubMed ID: 3178015
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of sorbitol, single, and multidose activated charcoal administration on carprofen absorption following experimental overdose in dogs.
    Koenigshof AM; Beal MW; Poppenga RH; Jutkowitz LA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(5):606-10. PubMed ID: 25891141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypernatremia due to repeated doses of charcoal-sorbitol.
    Allerton JP; Strom JA
    Am J Kidney Dis; 1991 May; 17(5):581-4. PubMed ID: 2024660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced activated charcoal delivery through small-bore tubing.
    Schneider SM; Michelson EA
    Vet Hum Toxicol; 1993 Dec; 35(6):503-5. PubMed ID: 8303817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of activated charcoal products for the treatment of poisonings.
    McFarland AK; Chyka PA
    Ann Pharmacother; 1993 Mar; 27(3):358-61. PubMed ID: 8453175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palatability of sucrose-, sorbitol-, and saccharin-sweetened activated charcoal formulations.
    Cooney DO
    Am J Hosp Pharm; 1980 Feb; 37(2):237-9. PubMed ID: 7361798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.